These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33621588)

  • 1. Progressive muscle loss is an independent predictor for survival in locally advanced oral cavity cancer: A longitudinal study.
    Lee J; Liu SH; Chen JC; Leu YS; Liu CJ; Chen YJ
    Radiother Oncol; 2021 May; 158():83-89. PubMed ID: 33621588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcopenia and Systemic Inflammation Synergistically Impact Survival in Oral Cavity Cancer.
    Lee J; Liu SH; Dai KY; Huang YM; Li CJ; Chen JC; Leu YS; Liu CJ; Chen YJ
    Laryngoscope; 2021 May; 131(5):E1530-E1538. PubMed ID: 33135827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancer.
    Huang CY; Yang YC; Chen TC; Chen JR; Chen YJ; Wu MH; Jan YT; Chang CL; Lee J
    J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):534-546. PubMed ID: 31999069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle radiodensity loss during cancer therapy is predictive for poor survival in advanced endometrial cancer.
    Lee J; Lin JB; Wu MH; Jan YT; Chang CL; Huang CY; Sun FJ; Chen YJ
    J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):814-826. PubMed ID: 31094101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of the skeletal muscle index and an inflammation biomarker in patients with breast cancer who underwent postoperative adjuvant radiotherapy.
    Hua X; Deng JP; Long ZQ; Zhang WW; Huang X; Wen W; Guo L; He ZY; Lin HX
    Curr Probl Cancer; 2020 Apr; 44(2):100513. PubMed ID: 31732239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of Third Cervical Vertebra Skeletal Muscle Index in Oral Cavity Cancer: A Retrospective Study.
    Chang SW; Hsu CM; Tsai YH; Chang GH; Tsai MS; Huang EI; Tsai YT
    Laryngoscope; 2021 Jul; 131(7):E2257-E2265. PubMed ID: 33433021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes and Predictive Value of Post-adjuvant Therapy PET/CT for Locally Advanced Oral Squamous Cell Carcinoma.
    Qian DC; Magliocca KR; Aiken AH; Baugnon KL; Brandon DC; Stokes WA; McDonald MW; Patel MR; Baddour HM; Kaka AS; Steuer CE; Saba NF; Shin DM; Beitler JJ
    Laryngoscope; 2020 Dec; 130(12):E850-E857. PubMed ID: 32057110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the prognosis of oral squamous cell carcinoma patients via L3 skeletal muscle index.
    Lu X; Tian Y; Huang J; Li F; Shao T; Huang G; Lv X
    Oral Dis; 2023 Apr; 29(3):923-932. PubMed ID: 34773352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of skeletal muscle measurement by computed tomography in patients with esophageal cancer: changes in skeletal muscle mass due to neoadjuvant therapy and the effect on the prognosis.
    Yamamoto M; Ozawa S; Koyanagi K; Kazuno A; Ninomiya Y; Yatabe K; Higuchi T; Kanamori K; Tajima K
    Surg Today; 2023 Jun; 53(6):692-701. PubMed ID: 36763134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Masticatory muscle index for indicating skeletal muscle mass in patients with head and neck cancer.
    Chang SW; Tsai YH; Hsu CM; Huang EI; Chang GH; Tsai MS; Tsai YT
    PLoS One; 2021; 16(5):e0251455. PubMed ID: 33970954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
    Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
    Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation of skeletal mass in locally advanced oesophageal cancer between initial diagnosis and recurrence.
    Zouhry Y; Taibi A; Durand-Fontanier S; Darbas T; Forestier G; Monteil J; Lebrun-Ly V; Fayemendy P; Leobon S; Jesus P; Deluche E
    BMC Cancer; 2021 Dec; 21(1):1313. PubMed ID: 34876055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors Associated with Disease Recurrence in Patients with Stage III/IV Squamous Cell Carcinoma of the Oral Cavity Treated with Surgery and Postoperative Radiotherapy.
    Noble AR; Greskovich JF; Han J; Reddy CA; Nwizu TI; Khan MF; Scharpf J; Adelstein DJ; Burkey BB; Koyfman SA
    Anticancer Res; 2016 Feb; 36(2):785-92. PubMed ID: 26851040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No influence of sarcopenia on survival of ovarian cancer patients in a prospective validation study.
    Ubachs J; Koole SN; Lahaye M; Fabris C; Bruijs L; Schagen van Leeuwen J; Schreuder HWR; Hermans RH; de Hingh IH; van der Velden J; Arts HJ; van Ham M; van Dam P; Vuylsteke P; Bastings J; Kruitwagen RFPM; Lambrechts S; Olde Damink SWM; Rensen SS; Van Gorp T; Sonke GS; van Driel WJ
    Gynecol Oncol; 2020 Dec; 159(3):706-711. PubMed ID: 33019981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of sarcopenia and sarcopenic obesity in patients affected by oral squamous cell carcinoma: A retrospective single-center study.
    Bonavolontà P; Improta G; Dell'Aversana Orabona G; Goglia F; Abbate V; Sorrentino A; Piloni S; Salzano G; Iaconetta G; Califano L
    J Craniomaxillofac Surg; 2023 Jan; 51(1):7-15. PubMed ID: 36739189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CT-assessed sarcopenia and prognostic nutritional index are associated with poor prognosis in oral squamous cell carcinoma.
    Ohyama Y; Inaba Y; Kubota M; Kanemaru T; Hasegawa K
    Oral Maxillofac Surg; 2024 Jun; 28(2):659-666. PubMed ID: 37935816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Skeletal Muscle Loss and Visceral Obesity Measured Using Serial CT on the Prognosis of Operable Breast Cancers in Asian Patients.
    Kwon MR; Ko ES; Park MS; Jeong WK; Hwang NY; Kim JH; Lee JE; Kim SW; Yu JH; Han BK; Ko EY; Choi JS; Park KW
    Korean J Radiol; 2022 Feb; 23(2):159-171. PubMed ID: 35029082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal Muscle Attenuation (Sarcopenia) Predicts Reduced Overall Survival in Patients with Advanced Epithelial Ovarian Cancer Undergoing Primary Debulking Surgery.
    Ataseven B; Luengo TG; du Bois A; Waltering KU; Traut A; Heitz F; Alesina PF; Prader S; Meier B; Schneider S; Koch JA; Walz M; Groeben HT; Nina P; Brunkhorst V; Heikaus S; Harter P
    Ann Surg Oncol; 2018 Oct; 25(11):3372-3379. PubMed ID: 30069659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
    Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
    BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.
    Choi Y; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
    PLoS One; 2015; 10(10):e0139749. PubMed ID: 26437072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.